Apellis Pharmaceuticals Ratios (2020-2025) | APLS

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 97.36%99.92%91.33%99.50%93.74%87.09%82.59%91.18%79.70%86.40%88.27%88.43%82.95%80.78%79.40%92.37%94.65%
EBT Margin 2,562.64%1,757.01%-21,421.21%48.28%4,399.02%-35,183.15%-3,461.43%-244.79%-957.70%-952.65%-865.18%-738.92%-395.79%-128.30%-126.82%-59.54%-38.45%-18.80%-28.88%-16.97%-55.09%-23.35%47.17%
EBIT Margin 2,520.69%1,671.85%-20,054.49%52.05%2,984.22%-31,185.71%-2,265.40%-148.29%-897.00%-910.57%-693.41%-723.88%-390.41%-126.82%-124.17%-57.74%-36.03%-14.74%-24.02%-12.31%-49.96%-18.65%48.67%
EBITDA Margin 4,278.08%1,726.70%-21,329.41%31.96%4,435.02%-35,216.69%-3,464.64%-245.50%-965.89%-962.58%-866.44%-722.94%-396.20%-128.52%-127.27%-62.20%-38.54%-18.78%-29.07%-17.18%-55.14%-23.34%47.08%
Operating Margin 2,520.69%1,671.85%-20,054.49%52.05%2,984.22%-31,185.71%-2,265.40%-148.29%-897.00%-910.57%-693.41%-723.88%-390.41%-126.82%-124.17%-57.74%-36.03%-14.74%-24.02%-12.31%-49.96%-18.65%48.67%
Net Margin 2,562.64%1,757.01%-21,421.21%48.28%4,399.02%-35,183.15%-3,461.43%-245.37%-966.10%-955.62%-867.20%-732.43%-396.46%-128.51%-127.03%-60.51%-38.56%-18.86%-29.19%-17.09%-55.29%-23.63%47.04%
FCF Margin 2,775.81%1,372.59%-16,031.27%56.51%3,683.78%-20,695.99%-2,990.74%-186.63%-776.34%-658.10%-701.00%-624.78%-396.64%-158.50%-153.20%-66.93%-77.34%-4.22%17.32%9.10%-32.03%2.46%23.62%
Efficiency
Inventory Average 0.00B0.01B0.02B0.04B0.05B0.07B0.09B0.09B0.10B0.12B0.15B0.16B0.14B0.10B0.08B0.10B0.12B
Assets Average 0.78B0.82B0.86B0.89B0.76B0.61B0.70B1.01B1.07B0.94B0.82B0.87B0.95B0.87B0.80B0.81B0.87B0.90B0.89B0.85B0.81B0.94B
Equity Average 0.25B0.17B0.16B0.13B-0.04B-0.10B0.07B0.33B0.06B-0.01B0.24B0.29B0.38B0.29B0.21B0.23B0.27B0.25B0.23B0.20B0.16B0.28B
Invested Capital 0.26B0.23B0.11B0.20B0.05B-0.14B-0.06B0.20B0.46B-0.33B0.31B0.17B0.41B0.35B0.23B0.19B0.27B0.26B0.24B0.23B0.16B0.16B0.49B
Asset Utilization Ratio 0.280.270.330.410.090.080.090.120.090.120.190.310.490.650.720.790.870.920.931.08
Leverage & Solvency
Interest Coverage Ratio -25.21-16.72-13.6413.54-29.84-51.58-56.09-29.62-15.11-17.59-19.35-21.20-23.25-16.41-18.75-11.42-8.91-3.15-3.77-2.27-7.54-2.9819.79
Debt to Equity 1.381.511.572.192.311.13
Debt Ratio 0.400.400.410.450.440.43
Equity Ratio 0.380.270.140.210.06-0.20-0.110.230.40-0.330.350.220.420.380.280.250.320.290.260.260.200.190.38
Times Interest Earned -25.21-16.72-13.6413.54-29.84-51.58-56.09-29.62-15.11-17.59-19.35-21.20-23.25-16.41-18.75-11.42-8.91-3.15-3.77-2.27-7.54-2.9819.79
Valuation
Enterprise Value 1.37B1.63B1.55B3.45B2.73B4.49B2.44B3.43B4.00B3.96B6.80B5.16B6.57B9.99B4.03B6.74B6.76B4.29B3.11B3.56B2.39B1.80B2.38B
Market Capitalization 2.02B2.47B2.28B4.33B3.45B5.09B2.87B4.13B4.97B4.82B7.50B5.72B7.34B10.61B4.48B7.09B7.09B4.66B3.51B3.97B2.75B2.18B2.86B
Return Ratios
Return on Sales -1.00%-1.35%-1.70%-1.89%-11.96%-8.67%-6.61%-5.61%-8.65%-6.53%-3.56%-2.22%-1.33%-0.80%-0.53%-0.35%-0.25%-0.29%-0.30%0.04%
Return on Capital Employed -0.29%-0.30%-0.53%-0.61%-0.94%-0.61%-0.52%-0.63%-0.92%-0.88%-0.79%-0.88%-0.93%-0.68%-0.45%-0.31%-0.23%-0.28%-0.31%0.12%
Return on Invested Capital -2.20%-1.62%-2.06%0.24%
Return on Assets -0.28%-0.36%-0.56%-0.78%-1.06%-0.69%-0.59%-0.68%-0.80%-0.79%-0.69%-0.70%-0.66%-0.51%-0.38%-0.28%-0.22%-0.26%-0.28%0.05%
Return on Equity -1.54%-2.52%9.36%4.81%-10.56%-2.12%-9.99%46.97%-2.73%-2.37%-1.73%-2.10%-2.48%-1.81%-1.25%-1.00%-0.85%-1.14%-1.42%0.16%